Recombinant multi-species CYP27B1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CYP27B1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The protein encoded by this gene localizes to the inner mitochondrial membrane where it hydroxylates 25-hydroxyvitamin D3 at the 1alpha position. This reaction synthesizes 1alpha,25-dihydroxyvitamin D3, the active form of vitamin D3, which binds to the vitamin D receptor and regulates calcium metabolism. Thus this enzyme regulates the level of biologically active vitamin D and plays an important role in calcium homeostasis. Mutations in this gene can result in vitamin D-dependent rickets type I. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 25-OHD-1 alpha-hydroxylase,25-hydroxyvitamin D(3) 1-alpha-hydroxylase (VD3 1A hydroxylase),25-hydroxyvitamin D-1 alpha hydroxylase,CP2B,CYP1,CYP1alpha,CYP27B,CYP27B1,Calcidiol 1-monooxygenase,Cp2b,Cyp1,Cyp27b,Cyp27b1,Cyp40,Cytochrome P450 subfamily XXVIIB polypeptide 1,Cytochrome P450C1 alpha,Cytochrome P450VD1-alpha,Cytochrome p450 27B1,P450c1,PDDR,Pddr,VDD1,VDDR,VDDRI,VDR,Vdd1,Vddr,VddrI,Vdr,mitochondrial
Go
to CYP27B1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP6010-Ag-1/ GM-Tg-hg-IP6010-Ag-2 | Human CYP27B1 protein | Human |
| GM-Tg-rg-IP6010-Ag-1/ GM-Tg-rg-IP6010-Ag-2 | Rat CYP27B1 protein | Rat |
| GM-Tg-mg-IP6010-Ag-1/ GM-Tg-mg-IP6010-Ag-2 | Mouse CYP27B1 protein | Mouse |
| GM-Tg-cynog-IP6010-Ag-1/ GM-Tg-cynog-IP6010-Ag-2 | Cynomolgus/Rhesus macaque CYP27B1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP6010-Ag-1/ GM-Tg-felg-IP6010-Ag-2 | Feline CYP27B1 protein | Feline |
| GM-Tg-cang-IP6010-Ag-1/ GM-Tg-cang-IP6010-Ag-2 | Canine CYP27B1 protein | Canine |
| GM-Tg-bovg-IP6010-Ag-1/ GM-Tg-bovg-IP6010-Ag-2 | Bovine CYP27B1 protein | Bovine |
| GM-Tg-equg-IP6010-Ag-1/ GM-Tg-equg-IP6010-Ag-2 | Equine CYP27B1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP6010-Ag-1/ GM-Tg-hg-IP6010-Ag-2;
GM-Tg-rg-IP6010-Ag-1/ GM-Tg-rg-IP6010-Ag-2;
GM-Tg-mg-IP6010-Ag-1/ GM-Tg-mg-IP6010-Ag-2; GM-Tg-cynog-IP6010-Ag-1/ GM-Tg-cynog-IP6010-Ag-2; GM-Tg-felg-IP6010-Ag-1/ GM-Tg-felg-IP6010-Ag-2; GM-Tg-cang-IP6010-Ag-1/ GM-Tg-cang-IP6010-Ag-2; GM-Tg-bovg-IP6010-Ag-1/ GM-Tg-bovg-IP6010-Ag-2; GM-Tg-equg-IP6010-Ag-1/ GM-Tg-equg-IP6010-Ag-2 |
| Products Name | CYP27B1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | CYP27B1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CYP27B1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.